# Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.

> **NCT04075422** · — · COMPLETED · sponsor: **Fundacion SEIMC-GESIDA** · enrollment: 869 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Bezlotoxumab Injection [Zinplava]

## Key facts

- **NCT ID:** NCT04075422
- **Lead sponsor:** Fundacion SEIMC-GESIDA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2021-08-05
- **Final completion:** 2022-10-28
- **Target enrollment:** 869 (ACTUAL)
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04075422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04075422, "Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04075422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*